Dr. Roy Freeman, Beth Israel Deaconess Medical Center, received funding from the NIH to pursue the review of specific drugs, newly approved or in development, to treat neuropathic pain in patients with diabetes. With a variety of drugs under review, the research focused on the mechanisms of action, preclinical supporting data, and adverse effects of the drugs. READ MORE
Source:Â Curr Diab Rep